John Hoekman

Insider Reports History

Location
Seattle, WA
Signature
/s/ John Leaman, M.D. as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Hoekman:

Company Role Class Num Shares Value Price $ Report Date Ownership
IMPEL PHARMACEUTICALS INC Chief Scientific Officer Stock Option (right to buy) 42,500 14 Feb 2023 Direct

Insider Reports Filed by John Hoekman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123010247-hoekman-john-2023-02-14 IMPEL PHARMACEUTICALS INC 14 Feb 2023 1 $0 4 Chief Scientific Officer 16 Feb 2023, 17:22
/report/000120919122005447-hoekman-john-2022-01-26 IMPEL NEUROPHARMA INC 26 Jan 2022 1 $0 4 Chief Scientific Officer 28 Jan 2022, 16:03
/report/000120919121071087-hoekman-john-2021-12-22 IMPEL NEUROPHARMA INC 22 Dec 2021 2 +$32,800 4 Chief Scientific Officer 23 Dec 2021, 15:50
/report/000120919121048218-hoekman-john-2021-07-20 IMPEL NEUROPHARMA INC 20 Jul 2021 1 $0 4 Chief Scientific Officer 26 Jul 2021, 17:58
/report/000120919121038665-hoekman-john-2021-04-27-restatement IMPEL NEUROPHARMA INC 27 Apr 2021 2 $0 4/A Chief Scientific Officer 07 Jun 2021, 16:57